Drug Channels Archive for July, 2025


Click a link below to view the mailing archive as if it had been sent to you.

2025-07-29 07:52Drug Channels News Roundup, July 2025: 340B vs. Patients, Humira Whiplash, Accumulator Fallout, and Pharmacy Struggles
2025-07-25 07:43Drug Channels - Beyond Throughput: Building Reverification Strategies That Safeguard Access
2025-07-22 07:49Drug Channels - 2024 Gross-to-Net Realities at 9 Top Drugmakers: A New Era of Market Access
2025-07-21 07:50Drug Channels - Informa Connect's Medicaid Drug Rebate Program Summit
2025-07-15 07:39Drug Channels - Gross-to-Net Bubble Hits $356B in 2024—But Growth Slows to 10-Year Low
2025-07-11 07:47Drug Channels - Rewriting the Access Script: A Pharmacist's View on the Rise of Direct-to-Patient
2025-07-08 07:14Drug Channels - The Stelara Biosimilar Price War: How PBM-Affiliated Private Labels Are Reshaping the Market

 

<< Archive IndexSubscribe >>